{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T03:30:57Z","timestamp":1780716657445,"version":"3.54.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Breast cancer diagnosed at a young age is often associated with aggressive tumor characteristics and poorer survival outcomes. In Southeast Asia, data on overall survival and prognostic factors among young women with breast cancer remain limited, particularly from real-world clinical settings with complete mortality ascertainment. This study aimed to describe survival outcomes and identify independent prognostic factors among women aged 45 years or younger with breast cancer at a major provincial referral hospital in Southern Thailand.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We conducted a retrospective cohort study of women aged 45 years or younger diagnosed with histologically confirmed breast cancer at Hat Yai Hospital, Southern Thailand, between 2013 and 2018. Mortality was ascertained through linkage with the Thai National Civil Registration database. Molecular subtypes were classified using immunohistochemistry surrogate criteria per the St. Gallen 2013 consensus. Missing data were handled using multiple imputation by chained equations (MICE, m\u2009=\u200910). Overall survival (OS), disease-free survival (DFS), and distant disease-free survival (DDFS) were estimated using the Kaplan\u2013Meier method. Prognostic factors were evaluated using univariable and multivariable Cox proportional hazards regression with the revised model including disease stage, tumour grade, molecular subtype, surgery, and hormone therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 293 young women were included. Median follow-up was 93.3 months (95% CI: 89.8\u201398.2). The 3-year and 5-year OS rates were 75.8% (95% CI: 71.0\u201380.8%) and 66.2% (95% CI: 61.0\u201371.9%), respectively. Five-year OS by stage ranged from 87.1% (Stage I) to 33.3% (Stage IV). The 5-year DFS and DDFS were 58.0% and 61.8%, respectively. The most common molecular subtype was HR+\/HER2- (52.0%), followed by HR-\/HER2- (22.3%), HR+\/HER2+ (16.0%), and HR-\/HER2+ (9.7%). In multivariable analysis, HR+\/HER2\u2009+\u2009subtype was independently associated with poorer overall survival compared with HR+\/HER2- (adjusted HR\u2009=\u20092.08, 95% CI: 1.07\u20134.07,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.032). Hormone therapy receipt was independently associated with better overall survival (adjusted HR\u2009=\u20090.20, 95% CI: 0.10\u20130.42,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Receipt of surgery was strongly associated with overall survival but largely reflected disease operability rather than an independent treatment effect.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study provides systematically ascertained, registry-linked survival benchmarks for young-onset breast cancer in Southern Thailand. HR+\/HER2\u2009+\u2009subtype and hormone therapy receipt were independent prognostic factors. The relatively lower stage-specific survival rates compared with high-income country benchmarks highlight the need for improved access to HER2-targeted therapy and endocrine therapy in this resource-limited setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12957-026-04349-9","type":"journal-article","created":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T06:36:25Z","timestamp":1776234985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Overall survival and prognostic factors in young women with breast cancer: a retrospective cohort study from Southern Thailand"],"prefix":"10.1186","volume":"24","author":[{"given":"Phungern","family":"Khongthong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanaporn","family":"Prateepchaiboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanyaporn","family":"Ruangsuwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"issue":"3","key":"4349_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"11","key":"4349_CR2","doi-asserted-by":"publisher","first-page":"103732","DOI":"10.1016\/j.esmoop.2024.103732","volume":"9","author":"J Kim","year":"2024","unstructured":"Kim J, Kim J, Seo KH, Lee KH, Park YH, Lin CH, et al. Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study. ESMO Open. 2024;9(11):103732.","journal-title":"ESMO Open"},{"issue":"2","key":"4349_CR3","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1097\/CEJ.0000000000000909","volume":"34","author":"Z Tang","year":"2025","unstructured":"Tang Z, Wei Y, Liang Y, Zhu X, Tang J, Sun Y, et al. Breast cancer burden among young women from 1990 to 2021: a global, regional, and national perspective. Eur J Cancer Prev. 2025;34(2):130\u20139.","journal-title":"Eur J Cancer Prev"},{"issue":"10","key":"4349_CR4","doi-asserted-by":"publisher","first-page":"6300","DOI":"10.21037\/tcr-2025-1059","volume":"14","author":"S Zhu","year":"2025","unstructured":"Zhu S, Zhang K, Lu W, Yang H, Yang C, Guo C, et al. Development and validation of nomograms predicting survival in operable breast cancer patients at reproductive age after breast conserving surgery and postoperative radiotherapy based on SEER database. Transl Cancer Res. 2025;14(10):6300\u201315.","journal-title":"Transl Cancer Res"},{"key":"4349_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ejca.2022.03.014","volume":"168","author":"E Shagisultanova","year":"2022","unstructured":"Shagisultanova E, Gao D, Callihan E, Parris HJ, Risendal B, Hines LM, et al. Overall survival is the lowest among young women with postpartum breast cancer. Eur J Cancer. 2022;168:119\u201327.","journal-title":"Eur J Cancer"},{"issue":"12","key":"4349_CR6","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1097\/CM9.0000000000002635","volume":"136","author":"X Ye","year":"2023","unstructured":"Ye X, Zhou X, He Q, Wang Z, Wang J, Ji M. Clinicopathological features and prognoses of very young patients (\u2264\u200935 years) with breast cancer: a retrospective population-based study in China. Chin Med J (Engl). 2023;136(12):1488\u201390.","journal-title":"Chin Med J (Engl)"},{"issue":"4","key":"4349_CR7","first-page":"428","volume":"27","author":"HL Chen","year":"2015","unstructured":"Chen HL, Ding A, Wang FW. Prognostic effect analysis of molecular subtype on young breast cancer patients. Chin J Cancer Res. 2015;27(4):428\u201336.","journal-title":"Chin J Cancer Res"},{"issue":"1","key":"4349_CR8","doi-asserted-by":"publisher","first-page":"11625","DOI":"10.1038\/s41598-017-10414-x","volume":"7","author":"W Lian","year":"2017","unstructured":"Lian W, Fu F, Lin Y, Lu M, Chen B, Yang P, et al. The Impact of Young Age for Prognosis by Subtype in Women with Early Breast Cancer. Sci Rep. 2017;7(1):11625.","journal-title":"Sci Rep"},{"issue":"2","key":"4349_CR9","first-page":"101","volume":"11","author":"DR Youlden","year":"2014","unstructured":"Youlden DR, Cramb SM, Yip CH, Baade PD. Incidence and mortality of female breast cancer in the Asia-Pacific region. Cancer Biol Med. 2014;11(2):101\u201315.","journal-title":"Cancer Biol Med"},{"issue":"1","key":"4349_CR10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1038\/s41598-020-58007-5","volume":"10","author":"PJ Ho","year":"2020","unstructured":"Ho PJ, Ow SGW, Sim Y, Liu J, Lim SH, Tan EY, et al. Impact of deviation from guideline recommended treatment on breast cancer survival in Asia. Sci Rep. 2020;10(1):1330.","journal-title":"Sci Rep"},{"key":"4349_CR11","doi-asserted-by":"publisher","first-page":"e085029","DOI":"10.1136\/bmj-2025-085029","volume":"390","author":"Z Ma","year":"2025","unstructured":"Ma Z, He W, Zhang Y, Mao X, Tapia J, Hall P, et al. First mammography screening participation and breast cancer incidence and mortality in the subsequent 25 years: population based cohort study. BMJ. 2025;390:e085029.","journal-title":"BMJ"},{"key":"4349_CR12","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.3389\/fonc.2020.01729","volume":"10","author":"S Cai","year":"2020","unstructured":"Cai S, Zuo W, Lu X, Gou Z, Zhou Y, Liu P, et al. The Prognostic Impact of Age at Diagnosis Upon Breast Cancer of Different Immunohistochemical Subtypes: A Surveillance, Epidemiology, and End Results (SEER) Population-Based Analysis. Front Oncol. 2020;10:1729.","journal-title":"Front Oncol"},{"issue":"6","key":"4349_CR13","doi-asserted-by":"publisher","first-page":"4911","DOI":"10.3892\/ol.2016.5360","volume":"12","author":"F De Lima Vazquez","year":"2016","unstructured":"De Lima Vazquez F, Silva TB, Da Costa Vieira RA, Da Costa AM, Scapulatempo C, Fregnani JH, et al. Retrospective analysis of breast cancer prognosis among young and older women in a Brazilian cohort of 738 patients, 1985\u20132002. Oncol Lett. 2016;12(6):4911\u201324.","journal-title":"Oncol Lett"},{"key":"4349_CR14","doi-asserted-by":"crossref","unstructured":"Li Y, Xin Y, Zhang C, Qi J, Tang Y, Li Z et al. The Impact of Young Age on Breast Cancer Prognosis: A Systematic Review and Meta-Analysis. Curr Cancer Drug Targets. 2025.","DOI":"10.2174\/0115680096369006250909091053"},{"issue":"1","key":"4349_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12885-021-09100-z","volume":"22","author":"Y Bouferraa","year":"2022","unstructured":"Bouferraa Y, Haibe Y, Chedid A, Jabra E, Charafeddine M, Temraz S, et al. The impact of young age (<\u200940 years) on the outcome of a cohort of patients with primary non-metastatic breast cancer: analysis of 10-year survival of a prospective study. BMC Cancer. 2022;22(1):27.","journal-title":"BMC Cancer"},{"key":"4349_CR16","doi-asserted-by":"publisher","first-page":"100643","DOI":"10.1016\/j.lansea.2025.100643","volume":"40","author":"A Pawar","year":"2025","unstructured":"Pawar A, Yalla P, Sharma M, Puj K, Aaron J, Warikoo V, et al. Clinicopathological characteristics and prognostic outcomes of young adult women (aged 18\u201330 years) with breast cancer in Ahmedabad, India: a single-centre, retrospective observational study. Lancet Reg Health Southeast Asia. 2025;40:100643.","journal-title":"Lancet Reg Health Southeast Asia"},{"issue":"1","key":"4349_CR17","doi-asserted-by":"publisher","first-page":"658","DOI":"10.18295\/2075-0528.2886","volume":"25","author":"K Shaikh","year":"2025","unstructured":"Shaikh K, Arif A, Mooghal M, Vohra L. Unveiling the Clinicopathological Outcomes of Breast Cancer in Young Women: A perspective from resource-limited settings. Sultan Qaboos Univ Med J. 2025;25(1):658\u201365.","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"1","key":"4349_CR18","doi-asserted-by":"publisher","first-page":"175","DOI":"10.21037\/gs-20-574","volume":"10","author":"W Zhang","year":"2021","unstructured":"Zhang W, Zhang BL, He JJ, Fan JH, Li J, Zhang B, et al. Clinicopathological characteristics and treatment of young women with breast cancer in China: a nationwide multicenter 10-year retrospective study. Gland Surg. 2021;10(1):175\u201385.","journal-title":"Gland Surg"},{"issue":"2","key":"4349_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.26719\/2020.26.2.219","volume":"26","author":"K Maajani","year":"2020","unstructured":"Maajani K, Khodadost M, Fattahi A, Pirouzi A. Survival rates of patients with breast cancer in countries in the Eastern Mediterranean Region: a systematic review and meta-analysis. East Mediterr Health J. 2020;26(2):219\u201332.","journal-title":"East Mediterr Health J"},{"issue":"8","key":"4349_CR20","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1007\/s00268-003-6976-x","volume":"27","author":"AN Hisham","year":"2003","unstructured":"Hisham AN, Yip CH. Spectrum of breast cancer in Malaysian women: overview. World J Surg. 2003;27(8):921\u20133.","journal-title":"World J Surg"},{"issue":"1","key":"4349_CR21","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13058-018-1033-8","volume":"20","author":"M Abubakar","year":"2018","unstructured":"Abubakar M, Sung H, Bcr D, Guida J, Tang TS, Pfeiffer RM, et al. Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population. Breast Cancer Res. 2018;20(1):114.","journal-title":"Breast Cancer Res"},{"issue":"1","key":"4349_CR22","doi-asserted-by":"publisher","first-page":"6433","DOI":"10.1038\/s41467-020-20173-5","volume":"11","author":"JW Pan","year":"2020","unstructured":"Pan JW, Zabidi MMA, Ng PS, Meng MY, Hasan SN, Sandey B, et al. The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences. Nat Commun. 2020;11(1):6433.","journal-title":"Nat Commun"},{"key":"4349_CR23","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.ejca.2022.06.011","volume":"173","author":"I Grootes","year":"2022","unstructured":"Grootes I, Keeman R, Blows FM, Milne RL, Giles GG, Swerdlow AJ, et al. Incorporating progesterone receptor expression into the PREDICT breast prognostic model. Eur J Cancer. 2022;173:178\u201393.","journal-title":"Eur J Cancer"},{"key":"4349_CR24","doi-asserted-by":"crossref","unstructured":"Lim YX, Lim ZL, Ho PJ, Li J. Breast Cancer in Asia: Incidence, Mortality, Early Detection, Mammography Programs, and Risk-Based Screening Initiatives. Cancers (Basel). 2022;14(17).","DOI":"10.3390\/cancers14174218"},{"key":"4349_CR25","doi-asserted-by":"crossref","unstructured":"Chen J, Ho FDV, Feliciano EJG, Wu JF, Magsanoc-Alikpala K, Dee EC. Trends in female breast cancer among adolescent and young adults in Southeast Asia. Volume 34. The Lancet Regional Health - Southeast Asia; 2025.","DOI":"10.1016\/j.lansea.2025.100545"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04349-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04349-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04349-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T01:30:20Z","timestamp":1779413420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04349-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4349"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04349-9","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"assertion":[{"value":"3 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Ethical approval was obtained from the Human Research Ethics Committee of Hatyai Hospital (approval number HYH EC 110-68-01). Due to the retrospective nature of the study and the use of de-identified data, the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"229"}}